These data, together with the evidence of association between high IL6 levels and neuroinflammation support IL6 as a promising drug target for PD and other neurodegenerative diseases mediated by neuroinflammation (Garbers et al., 2018). The gene discussed is IL6; the disease is neurodegenerative disease.